Efficacy and Safety of Ammoxetine in Major Depressive Disorder
1. Ammoxetine, a novel SNRI developed from duloxetine, was effective at treating adults with major depressive disorder (MDD) and was ...
1. Ammoxetine, a novel SNRI developed from duloxetine, was effective at treating adults with major depressive disorder (MDD) and was ...
Factors in the Initial Resuscitation of Patients With Severe Trauma: The FiiRST-2 Randomized Clinical Trial 1. Replacing clotting factors with ...
1. Compared to standard care, measurement-based care resulted in faster time to response and time to remission among adults with ...
1. Measurement-based care (MBC) significantly accelerates recovery from major depressive disorder, leading patients to achieve response and remission in half ...
Effectiveness and user experiences of a valgus brace in patients with knee osteoarthritis: A mixed-method randomised controlled trial 1. After ...
1. Mean MADRS change at week 6 was -8.2 in the active tDCS group versus -8.0 in the sham tDCS ...
1. In a large population-based cohort, age-related macular degeneration (AMD) diagnosis was associated with increased risk for depression onset. 2. ...
1. Psilocybin treatment was shown not to report significantly improved self-reported depression scores compared to escitalopram treatment in patients with ...
1. In this modeling study comparing the cost-effectiveness of cognitive behavioral therapy (CBT) with second-generation antidepressants (SGA) for initial treatment ...
1. In this randomized controlled trial, patients with Major depressive disorder with psychotic features who were stable on olanzapine and ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.